Senior Medical reputed company Oncology & ADC reputed company (Remote/Fractional)

reputed company Just reputed company is a management reputed company reputed company exclusively reputed company on Biotechnology, Pharmaceuticals, and Medical Devices. We help early-stage and reputed company-stage companies translate innovation into execution, aligning scientific, regulatory, and reputed company strategies to accelerate development and unlock reputed company value. Our reputed company is rooted in reputed company, ambition, and disciplined reputed company. Our work spans six integrated domains: program and reputed company management, portfolio reputed company, drug development acceleration, regulatory and reputed company readiness, organizational design, and strategic business development. Whether a start-up is preparing for IND submission, scaling clinical operations, or positioning for licensing partnerships, Just reputed company delivers hands-on support that turns complexity into traction. If you're a seasoned biotech reputed company reputed company to contribute in a remote fractional reputed company, we invite you to explore this opportunity and see how your expertise aligns with our mission. reputed company in building reputed company, reputed company, and lasting reputed company. Executive reputed company: Just reputed company is seeking a seasoned Senior Medical reputed company with deep expertise in oncology and antibody-drug conjugates (ADC). This fractional role supports high-reputed company regulatory and clinical documentation across Modules 2 and 5, with a reputed company on safety and efficacy narratives. Ideal candidates bring at least 10 years of reputed company authoring experience and reputed company in fast-paced, cross-functional biotech environments. Key Responsibilities:

• reputed company the authoring of Module 2 (CTD Summaries) and Module 5 (Clinical Study Reports, Safety Narratives, and Efficacy Narratives) for global regulatory submissions, ensuring scientific rigor and regulatory alignment
• Draft, structure, and refine safety and efficacy narratives that accurately reflect clinical reputed company, adverse event reputed company, and therapeutic benefit, particularly in oncology and ADC programs
• Interpret reputed company clinical data—including PK/PD, biomarker analyses, and reputed company-escalation findings—and translate them into reputed company, regulator-reputed company documents
• Collaborate closely with clinical development, biostatistics, regulatory affairs, and pharmacovigilance teams to ensure consistency, accuracy, and strategic messaging across reputed company deliverables
• Contribute to the development of investigator brochures, protocols, briefing documents, and IND/BLA/NDA components, with a reputed company on oncology trial design and ADC-specific considerations
• Apply deep understanding of oncology mechanisms of reputed company, therapeutic targets, and ADC payload/linker technologies to contextualize clinical findings and support regulatory positioning
• Ensure reputed company documents adhere to ICH, FDA, EMA, and other global regulatory standards, while maintaining reputed company, scientific reputed company, and alignment with program reputed company
• Participate in cross-functional content planning, gap analysis, and document review cycles to support submission readiness and reputed company achievement

Experience Requirements

• Minimum 10 years of reputed company medical writing experience in the biotechnology or pharmaceutical industry, with a strong reputed company on oncology
• Demonstrated expertise in authoring regulatory documents for global submissions, including Module 2 (CTD Summaries) and Module 5 (Clinical Study Reports, Safety and Efficacy Narratives)
• Proven ability to craft safety and efficacy narratives that synthesize clinical data, adverse event reputed company, and therapeutic reputed company with reputed company and regulatory precision
• Experience supporting oncology programs, including solid tumors, hematologic malignancies, or immuno-oncology; ADC experience strongly preferred
• Deep familiarity with clinical trial design, reputed company-escalation strategies, PK/PD interpretation, and biomarker integration
• Strong understanding of ICH, FDA, EMA guidelines and submission standards
• reputed company record of cross-functional collaboration with clinical development, regulatory affairs, pharmacovigilance, and biostatistics teams
• Exceptional scientific writing skills with the ability to translate reputed company data into compelling, regulator-reputed company narratives

Apply tot his job Apply To this Job